Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Samjin characterizes novel antitumor agent

May 14, 1997

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

May 14, 1997

In vivo growth arrest of mammary carcinoma by ibuprofen

May 14, 1997

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

In vivo and clinical antitumor activity of recombinant methioninase

May 14, 1997

Lilly synthesizes antifolates that potently inhibit human DHFR

May 14, 1997

Clinical results for Zambon's N-acetylcysteine as chemopreventive agent

May 14, 1997

Clinical results for titanocene dichloride in solid tumors

May 14, 1997

In vivo and in vitro characterization of the novel vinca alkaloid F-12158

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...